These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 9694031

  • 1. 5-HT1A receptor agonist (8-OH-DPAT) and 5-HT2 receptor agonist (DOI) disrupt the non-cognitive performance of rats in a working memory task.
    Ruotsalainen S, MacDonald E, Koivisto E, Stefanski R, Haapalinna A, Riekkinen P, Sirviö J.
    J Psychopharmacol; 1998; 12(2):177-85. PubMed ID: 9694031
    [Abstract] [Full Text] [Related]

  • 2. Effects of 5-HT1A, 5-HT2A and 5-HT2C receptor agonists and antagonists on responding for a conditioned reinforcer and its enhancement by methylphenidate.
    Fletcher PJ, Zeeb FD, Browne CJ, Higgins GA, Soko AD.
    Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
    [Abstract] [Full Text] [Related]

  • 3. The 5-HT(1A) receptor agonist 8-OH-DPAT reduces rats' accuracy of attentional performance and enhances impulsive responding in a five-choice serial reaction time task: role of presynaptic 5-HT(1A) receptors.
    Carli M, Samanin R.
    Psychopharmacology (Berl); 2000 Apr; 149(3):259-68. PubMed ID: 10823407
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the effects of clozapine and 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on progressive ratio schedule performance: evidence against the involvement of 5-HT1A receptors in the behavioural effects of clozapine.
    Zhang Z, Rickard JF, Body S, Asgari K, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2005 Sep; 181(2):381-91. PubMed ID: 15830225
    [Abstract] [Full Text] [Related]

  • 5. The 5-HT1A receptor full agonist, 8-OH-DPAT inhibits ACTH-induced 5-HT2A receptor hyperfunction in rats: involvement of 5-HT1A receptors in the DOI-induced wet-dog shakes in ACTH-treated rats.
    Kitamura Y, Kitagawa K, Fujitani Y, Shibata K, Araki H, Sendou T, Gomita Y.
    Biol Pharm Bull; 2007 Jan; 30(1):117-20. PubMed ID: 17202670
    [Abstract] [Full Text] [Related]

  • 6. 5-HT1A and muscarinic acetylcholine receptors jointly regulate passive avoidance behavior.
    Riekkinen P.
    Eur J Pharmacol; 1994 Sep 01; 262(1-2):77-90. PubMed ID: 7813581
    [Abstract] [Full Text] [Related]

  • 7. Enhancement and depression of spinal reflexes by 8-hydroxy-2-(di-n-propylamino)tetralin in the decerebrated and spinalized rabbit: involvement of 5-HT1A- and non-5-HT1A-receptors.
    Clarke RW, Ogilvie J, Houghton AK.
    Br J Pharmacol; 1997 Oct 01; 122(4):631-8. PubMed ID: 9375958
    [Abstract] [Full Text] [Related]

  • 8. Genomic responses to 5-HT1A or 5-HT2A/2C receptor activation is differentially regulated in four regions of rat brain.
    Tilakaratne N, Friedman E.
    Eur J Pharmacol; 1996 Jun 27; 307(2):211-7. PubMed ID: 8832223
    [Abstract] [Full Text] [Related]

  • 9. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I, Ogren SO.
    Neuropsychopharmacology; 2000 Feb 27; 22(2):168-90. PubMed ID: 10649830
    [Abstract] [Full Text] [Related]

  • 10. Failure of central 5-hydroxytryptamine depletion to alter the effect of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on timing performance on the free-operant psychophysical procedure.
    Body S, Chiang TJ, Mobini S, Ho MY, Bradshaw CM, Szabadi E.
    Psychopharmacology (Berl); 2001 Nov 27; 158(3):305-13. PubMed ID: 11713621
    [Abstract] [Full Text] [Related]

  • 11. Differential effects of 5-HT agonists and antagonists on the repeated acquisition and performance of response sequences in monkeys.
    Winsauer PJ, Moerschbaecher JM.
    Behav Pharmacol; 2000 Nov 27; 11(7-8):535-53. PubMed ID: 11198126
    [Abstract] [Full Text] [Related]

  • 12. N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline studies on the role of 5-HT1A and 5-HT2 receptors in mediating foot-shock-induced ultrasonic vocalisation in adult rats.
    Sánchez C, Mørk A.
    Eur Neuropsychopharmacol; 1999 Jun 27; 9(4):287-94. PubMed ID: 10422888
    [Abstract] [Full Text] [Related]

  • 13. Different effects of 5-HT receptor agonists on operant response in rats under DRL 10-s and DRL 30-s schedules.
    Liao RM, Chang YH.
    Proc Natl Sci Counc Repub China B; 2001 Oct 27; 25(4):223-32. PubMed ID: 11699570
    [Abstract] [Full Text] [Related]

  • 14. Antagonism by WAY-100635 of the effects of 8-OH-DPAT on performance on a free-operant timing schedule in intact and 5-HT-depleted rats.
    Body S, Kheramin S, Mobini S, Ho MY, Velazquez-Martinez DN, Bradshaw CM, Szabadi E.
    Behav Pharmacol; 2002 Dec 27; 13(8):603-14. PubMed ID: 12478210
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT(2A/2C) antagonist anxiolytics. II. Drug discrimination and behavioral observation studies in rats.
    Kleven MS, Assié MB, Koek W.
    J Pharmacol Exp Ther; 1997 Aug 27; 282(2):747-59. PubMed ID: 9262338
    [Abstract] [Full Text] [Related]

  • 16. The effects of long-term treatment with the 5-HT1A receptor agonist 8-OH-DPAT and the 5-HT2/1C receptor agonist DOI in the neonatal rat.
    Johansson-Wallsten CE, Berg M, Meyerson BJ.
    Eur J Pharmacol; 1993 Oct 19; 243(2):149-54. PubMed ID: 8276064
    [Abstract] [Full Text] [Related]

  • 17. Reversal of fenfluramine and fluoxetine anorexia by 8-OH-DPAT is attenuated following raphe injection of 5,7-dihydroxytryptamine.
    Currie PJ, Coscina DV, Fletcher PJ.
    Brain Res; 1998 Jul 27; 800(1):62-8. PubMed ID: 9685586
    [Abstract] [Full Text] [Related]

  • 18. Effects of 8-OH-DPAT, a 5-HT1A receptor agonist, and DOI, a 5-HT2A/2C agonist, on monosynaptic transmission in spinalized rats.
    Hasegawa Y, Ono H.
    Brain Res; 1996 Oct 28; 738(1):158-61. PubMed ID: 8949941
    [Abstract] [Full Text] [Related]

  • 19. Serotonergic mechanisms involved in the attentional and vigilance task performance of rats and the palliative action of aniracetam.
    Nakamura K, Kurasawa M.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 May 28; 361(5):521-8. PubMed ID: 10832606
    [Abstract] [Full Text] [Related]

  • 20. Discriminative stimulus properties of indorenate, a 5-HT1A, 5-HT1B and 5-HT2C agonist: a study in rats.
    Sánchez H, Velázquez-Martínez DN.
    J Psychopharmacol; 2001 Mar 28; 15(1):29-36. PubMed ID: 11277605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.